The IDF Diabetes Atlas is the authoritative resource on the global burden of diabetes. First published in 2000, it is produced by IDF biennially in collaboration with experts from around the world and contains data on diabetes cases, prevalence, mortality and expenditure on the global, regional and national level.
Figures from the Atlas are frequently quoted in scientific papers and by the media. The IDF Diabetes Atlas is considered as one of IDF’s most valuable and visible projects. A full IDF Diabetes Atlas report is produced every two years.
The Atlas is supported by: Astra Zeneca; Lilly Diabetes; Merck; Novo Nordisk.